Related Experiment Video
Updated: Jan 9, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective
Yih-Chung Tham1,2, Ching-Yu Cheng1,2,3
1Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Primary open angle glaucoma (POAG) is a major cause of blindness. This review explores how chronic systemic diseases like hypertension and diabetes may increase POAG risk, aiding early detection efforts.
Area of Science:
- Ophthalmology
- Public Health
- Epidemiology
Background:
- Glaucoma is a leading cause of irreversible blindness globally.
- Primary open angle glaucoma (POAG) affects millions worldwide.
- Elevated intraocular pressure and optic nerve head vascular impairment are key POAG processes.
Purpose of the Study:
- To review evidence linking chronic systemic diseases to POAG.
- To identify potential risk factors for POAG.
- To support early detection strategies for POAG.
Main Methods:
- Literature review of studies on systemic diseases and POAG.
- Analysis of associations between hypertension, diabetes, obesity, and POAG.
- Synthesis of current evidence on pathogenic links.
Main Results:
- Chronic systemic conditions are postulated to correlate with POAG pathogenesis.
- Hypertension, diabetes, and obesity are investigated as potential POAG risk factors.
- Evidence suggests a plausible link between these diseases and POAG.
Conclusions:
- Chronic systemic diseases may serve as risk factors for POAG.
- Understanding these associations can refine POAG risk assessment.
- Further research can improve early POAG detection and prevention.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease I: Introduction
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways

